Survival outcomes and response to immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma: a retrospective study of 81 patients

Further Publications Immunology

Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital

Acta Derm Venereol

Juan-Carpena G, Martínez Banaclocha N, Palazón Cabanes JC, Niveiro-de Jaime M, Betlloch Mas I, Blanes-Martínez M

doi: 10.2340/actadv.v105.42023

Melanoma and Skin CancerImmunotherapy

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

J Am Acad Dermatol

Paulson KG, Park SY, Bhatia S, Hippe DS, Nghiem P

doi: 10.1016/j.jaad.2025.03.006

Melanoma and Skin Cancer

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL)

Br J Dermatol

Nardin C, Cavalieri C, Lebbé C, Gérard E, Puyraveau M, Vergara R, Maubec E, Kramkimel N, Lesage C, Rouanet J, Bonniaud B, Puzenat E, Popescu D, Baroudjian B, Le Corre Y, Saiag P, Brunet Possenti F, Saint-Jean M, Montaudié H, Amini-Adle M, Belkaid S, Grange F, Mansard S, Béjar CL, Darras S, Pages C, Tournier E, Funck-Brentano E, Aubin F

doi: 10.1093/bjd/ljaf268

Melanoma and Skin CancerFurther Publications Rheumatology

Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma

J Autoimmun

Tenstad HB, Ruhlmann CH, Möller S, Kjaer S, Bastholt L, Just SA, Lindegaard H

doi: 10.1016/j.jaut.2025.103400

Melanoma and Skin Cancer

Disparities in Survival and Tumor Characteristics in Patients With Single and Multiple Primary Merkel Cell Carcinomas

J Am Acad Dermatol

Luo Z, Sun Y, Guo Z, Le J, Zhang S, Yu Y, Xu S, Zeng F, Deng G

doi: 10.1016/j.jaad.2025.08.052

Melanoma and Skin Cancer

A comparative study of Merkel cell carcinoma and melanoma incidence and survival in the United States, 2000-2021

J Invest Dermatol

Tribble JT, Brownell I, Cahoon EK, Sargen MR, Shiels MS, Engels EA, Volesky-Avellaneda KD

doi: 10.1016/j.jid.2024.12.014

Melanoma and Skin Cancer

A multivariable disease specific model enhances prognostication beyond current Merkel cell carcinoma staging: an international cohort study of 10,958 patients

J Am Acad Dermatol

Andrew TW, Erdmann S, Alrawi M, Plummer R, Shalhout SZ, Sondak V, Brownell I, Lovat PE, Rose A

doi: 10.1016/j.jaad.2024.10.096

Melanoma and Skin Cancer

The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study

Ann Dermatol Venereol

Amici M, Neveu E, Poizeau F, Edeline J, Lesimple T, Oger E, Danton G, Dupuy A, Fouchard M

doi: 10.1016/j.annder.2025.103371

Melanoma and Skin Cancer

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort

Melanoma Res

Macaire C, Lefevre W, Dalac S, Montaudié H, Legoupil D, Dereure O, Dutriaux C, Leccia MT, Aubin F, Grob JJ, Saiag P, De Quatrebarbes J, Maubec E, Lesimple T, Granel-Brocard F, Mortier L, Dalle S, Lebbé C, Prod'homme C

doi: 10.1097/CMR.0000000000000973

Related content

Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL)

Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma

Disparities in Survival and Tumor Characteristics in Patients With Single and Multiple Primary Merkel Cell Carcinomas

A comparative study of Merkel cell carcinoma and melanoma incidence and survival in the United States, 2000-2021

A multivariable disease specific model enhances prognostication beyond current Merkel cell carcinoma staging: an international cohort study of 10,958 patients

The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study

Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort